These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18206631)

  • 1. Removal of contrast medium from the coronary sinus during coronary angiography: feasibility of a simple and available technique for the prevention of nephropathy.
    Danenberg HD; Lotan C; Varshitski B; Rosenheck S; Weiss AT
    Cardiovasc Revasc Med; 2008; 9(1):9-13. PubMed ID: 18206631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Coronary Sinus Aspiration During Coronary Angiography to Attenuate the Risk of Contrast-Induced Acute Kidney Injury in Predisposed Patients.
    Diab OA; Helmy M; Gomaa Y; El-Shalakany R
    Circ Cardiovasc Interv; 2017 Jan; 10(1):e004348. PubMed ID: 28049622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast removal from coronary sinus for prevention of contrast-induced nephropathy: a review.
    Irannejad K; Vakhshoori M; Khoubyari R; Movahed MR
    Future Cardiol; 2023 Apr; 19(5):283-299. PubMed ID: 37466075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An initiative to minimize amount of contrast media utilizing a novel rotational coronary sinus occlusive venography technique with ordinary cath-lab X-ray machine during CRT implantation.
    Al Fagih A; Al Ghamdi S; El Tayeb A; Dagriri K
    J Invasive Cardiol; 2010 Sep; 22(9):428-31. PubMed ID: 20814050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel contrast removal system from the coronary sinus using an adsorbing column during coronary angiography in a porcine model.
    Michishita I; Fujii Z
    J Am Coll Cardiol; 2006 May; 47(9):1866-70. PubMed ID: 16682314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty.
    Aslanger E; Uslu B; Akdeniz C; Polat N; Cizgici Y; Oflaz H
    Coron Artery Dis; 2012 Jun; 23(4):265-70. PubMed ID: 22343798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
    Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Technique for Endovascular Detection and Removal of Radiographic Contrast during Angiography.
    Chang H; Hassan AH; Kim YL; Lloyd LJ; Koo BK; Ako J; Honda Y; Davidson CJ; Fitzgerald PJ
    J Invasive Cardiol; 2009 Jul; 21(7):314-8. PubMed ID: 19571339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
    Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention.
    Duffy SJ; Ruygrok P; Juergens CP; Sievert H; Richards M; Blake J; Whitbourn R; Farouque HO; Pertile T; Kaye DM
    J Am Coll Cardiol; 2010 Aug; 56(6):525-6. PubMed ID: 20670766
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
    Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
    Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical impact of nephropathy induced by contrast medium in patients with acute myocardial infarction undergoing emergent coronary angiography].
    Jujo K; Yamaguchi J; Obayashi K; Suzuki K; Sekiguchi H; Nagashima M; Tsurumi Y; Kasanuki H
    J Cardiol; 2006 Jul; 48(1):9-16. PubMed ID: 16886495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial.
    Dvoršak B; Kanič V; Ekart R; Bevc S; Hojs R
    Ther Apher Dial; 2013 Aug; 17(4):384-90. PubMed ID: 23931876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular detection and removal of radiographic contrast.
    Hassan AH; Luna J; Davidson CJ; Fitzgerald PJ
    Cardiovasc Revasc Med; 2010; 11(2):114-5. PubMed ID: 20347803
    [No Abstract]   [Full Text] [Related]  

  • 15. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the usefulness of gadodiamide and iodine mixture versus iodinated contrast alone for prevention of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography.
    Reed PS; Dixon SR; Boura JA; O'Neill WW; Kahn JK
    Am J Cardiol; 2007 Oct; 100(7):1090-3. PubMed ID: 17884368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials.
    Liu YH; Liu Y; Duan CY; Tan N; Chen JY; Zhou YL; Li LW; He PC
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):181-92. PubMed ID: 25193735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial.
    Angoulvant D; Cucherat M; Rioufol G; Finet G; Beaune J; Revel D; Laville M; Ovize M; André-Fouët X
    Arch Cardiovasc Dis; 2009 Nov; 102(11):761-7. PubMed ID: 19944392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.
    Jo SH; Koo BK; Park JS; Kang HJ; Cho YS; Kim YJ; Youn TJ; Chung WY; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2008 Mar; 155(3):499.e1-8. PubMed ID: 18294484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
    Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.